Answer: c) Entacapone.
Entacapone is a selective and reversible COMT inhibitor which
inhibits metabolism of Levodopa thus increases plasma levels of Levodopa which
is needed for more constant dopaminergic stimulation that is required to reduce
the signs and symptoms presented in Parkinson’s disease.
No comments:
Post a Comment